SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001664710-20-000057
Filing Date
2020-12-07
Accepted
2020-12-07 08:11:01
Documents
7
Period of Report
2020-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K keros-form8xkash2020pr.htm 8-K 31677
2 EX-99.1 exhibit991ash2020pr.htm EX-99.1 34354
3 GRAPHIC image1.jpg GRAPHIC 132387
4 GRAPHIC image2.jpg GRAPHIC 83692
5 GRAPHIC image3.jpg GRAPHIC 68621
6 GRAPHIC image4a.jpg GRAPHIC 73483
7 GRAPHIC image5a.jpg GRAPHIC 67931
  Complete submission text file 0001664710-20-000057.txt   654726
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 201371403
SIC: 2834 Pharmaceutical Preparations